Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction

NCT05672134 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT05672134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 2
Overall status
Completed
Start date
April 26, 2023
Completion date
August 30, 2024
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction